FINHUB Insights

TMO · Q1 FY26 · Mar 28, 2026

Thermo Fisher Scientific Q1 FY26: where the revenue came from and where it went

Thermo Fisher Scientific Q1 FY26: revenue $11B (+6% year over year). Net profit $1.7B. Largest cohort Service $4.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 28, 2026
Reported
May 1, 2026 10-Q
Sankey diagram of Thermo Fisher Scientific's income statement for Q1 FY26: revenue of $11 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$11B +6% year over year
Gross profit$4.4B 40% margin
Operating profit$1.9B 17% margin
Net profit$1.7B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 28, 2026).
ItemValueShare of revenueYear over year
Revenue 11 100% +6%
Service 4.7 43% +8%
Consumables 4.7 43% +8%
Instruments 1.6 15% −4%
Cost of revenue−6.761%
Gross profit4.440% margin+0pp
Research & development−0.33%+0pp
SG&A−2.220%+0pp
Operating profit1.917% margin+0pp
Tax−0.1
Interest & other costs−0.1
Net profit1.715%+0pp
Filing on EDGAR More quarters of TMO

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters